Futura Medical Developments Limited Sustainability Profile
Futura Medical Developments Limited, often referred to as Futura Medical, is a pioneering company headquartered in Great Britain. Established in 2001, Futura Medical has made significant strides in the pharmaceutical and medical device industries, focusing primarily on innovative solutions for sexual health and pain management. The company is renowned for its unique transdermal delivery systems, which offer effective treatments with enhanced patient compliance. Futura Medical's flagship product, the MED3000, is a groundbreaking topical gel designed to treat erectile dysfunction, setting it apart in a competitive market. With a commitment to research and development, Futura Medical has positioned itself as a leader in its field, achieving notable milestones in regulatory approvals and clinical trials. Its dedication to innovation continues to drive its success and reputation within the healthcare sector.
DitchCarbon Score
How does Futura Medical Developments Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Computer Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Futura Medical Developments Limited's score of 26 is lower than 55% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Futura Medical Developments Limited's reported carbon emissions
Futura Medical Developments Limited, headquartered in Great Britain, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures. The company has not established any documented reduction targets or commitments to climate initiatives, such as those outlined by the Science Based Targets initiative (SBTi) or other industry standards. As a current subsidiary, Futura Medical's climate commitments and emissions data may be influenced by its corporate family relationships, but no specific cascading data from a parent organization has been provided. Without concrete emissions figures or reduction initiatives, it is challenging to assess the company's environmental impact or commitments to sustainability. In the context of the industry, it is essential for companies like Futura Medical to develop and communicate clear climate strategies to align with global efforts to reduce greenhouse gas emissions and combat climate change.
How Carbon Intensive is Futura Medical Developments Limited's Industry?
How Carbon Intensive is Futura Medical Developments Limited's Location?
Futura Medical Developments Limited's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Futura Medical Developments Limited has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
